Overall, our data establish the PI3K-phospho-YBX1 axis as an oncogenic driver of tumour growth in patient HNC basal subtype and the YBX1 factor as a suppressor of metastasis in the mesenchymal subtype (Fig. 7). This evidence concerns the gene YBX1 and neoplasm.